Amdocs Stock Performance

DOX Stock  USD 91.12  0.11  0.12%   
Amdocs has a performance score of 10 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.64, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Amdocs' returns are expected to increase less than the market. However, during the bear market, the loss of holding Amdocs is expected to be smaller as well. Amdocs right now shows a risk of 1.05%. Please confirm Amdocs potential upside, and the relationship between the jensen alpha and accumulation distribution , to decide if Amdocs will be following its price patterns.

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Amdocs are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Amdocs may actually be approaching a critical reversion point that can send shares even higher in May 2025. ...more

Actual Historical Performance (%)

One Day Return
0.12
Five Day Return
(0.77)
Year To Date Return
8.27
Ten Year Return
69.68
All Time Return
550.86
Forward Dividend Yield
0.0232
Payout Ratio
0.3003
Forward Dividend Rate
2.11
Dividend Date
2025-04-25
Ex Dividend Date
2025-03-31
JavaScript chart by amCharts 3.21.1512345678910112025FebMar -6-4-20246
JavaScript chart by amCharts 3.21.15Amdocs Amdocs Dividend Benchmark Dow Jones Industrial
 
Amdocs dividend paid on 31st of January 2025
01/31/2025
1
Amdocs Ltd Launches AI Factory to Revolutionize Generative AI Monetization
02/21/2025
2
AI Factories Separating Hype From Reality
02/26/2025
3
Amdocs Ltd Announces CFO COOs Participation in Morgan Stanley Conference
03/04/2025
4
Amdocs Getting Closer To Key Technical Measure
03/07/2025
5
Returns On Capital At Amdocs Have Stalled
03/12/2025
6
Amdocs Limited Among the Best Mid Cap Tech Stocks to Buy Now
03/18/2025
7
Amdocs Limiteds Stock Has Shown A Decent Performance Have Financials A Role To Play
03/19/2025
8
Parallel Advisors LLC Reduces Stock Position in Amdocs Limited
03/21/2025
9
3 Reasons to Avoid DOX and 1 Stock to Buy Instead
03/24/2025
10
Amdocs Limited Shares Sold by Maryland State Retirement Pension System
03/25/2025
11
Should You Hold on to SMTC Stock Despite its 47 percent Decline in 3 Months
04/02/2025
Begin Period Cash Flow520.1 M
  

Amdocs Relative Risk vs. Return Landscape

If you would invest  8,368  in Amdocs on January 3, 2025 and sell it today you would earn a total of  744.00  from holding Amdocs or generate 8.89% return on investment over 90 days. Amdocs is generating 0.1451% of daily returns assuming volatility of 1.0473% on return distribution over 90 days investment horizon. In other words, 9% of stocks are less volatile than Amdocs, and above 98% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
JavaScript chart by amCharts 3.21.15CashMarketDOX 0.00.20.40.60.81.01.2 -0.020.000.020.040.060.080.100.120.140.16
       Risk  
Considering the 90-day investment horizon Amdocs is expected to generate 1.19 times more return on investment than the market. However, the company is 1.19 times more volatile than its market benchmark. It trades about 0.14 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.02 per unit of risk.

Amdocs Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Amdocs' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Amdocs, and traders can use it to determine the average amount a Amdocs' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1386

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashDOXAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 1.05
  actual daily
9
91% of assets are more volatile

Expected Return

 0.15
  actual daily
3
97% of assets have higher returns

Risk-Adjusted Return

 0.14
  actual daily
10
90% of assets perform better
Based on monthly moving average Amdocs is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amdocs by adding it to a well-diversified portfolio.

Amdocs Fundamentals Growth

Amdocs Stock prices reflect investors' perceptions of the future prospects and financial health of Amdocs, and Amdocs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Amdocs Stock performance.
Return On Equity0.14
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150%100%150%200%
Return On Asset0.0765
Profit Margin0.10 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100%200%300%400%500%600%700%
Operating Margin0.19 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-50%-40%-30%-20%-10%
Current Valuation10.65 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-15%-10%-5%0%5%10%15%
Shares Outstanding112.16 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-40%-30%-20%-10%
Price To Earning19.03 X
Price To Book2.95 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%
Price To Sales2.10 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%
Revenue5 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%
Gross Profit1.75 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%
EBITDA819.03 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%1,000%
Net Income496.32 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312,000%4,000%6,000%8,000%10,000%12,000%
Cash And Equivalents817.98 M
Cash Per Share6.74 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%2,500%3,000%
Total Debt789.74 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%5,000%6,000%7,000%
Debt To Equity0.23 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-50%0%50%
Current Ratio1.60 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-10%0%10%20%30%40%50%
Book Value Per Share30.89 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%5,000%6,000%
Cash Flow From Operations724.43 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%2,500%3,000%3,500%
Earnings Per Share4.32 X
Market Capitalization10.22 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-10%-5%0%5%10%15%20%
Total Asset6.39 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%2,500%3,000%
Retained Earnings6.83 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-60,000%-50,000%-40,000%-30,000%-20,000%-10,000%
Working Capital300.27 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Current Asset2.1 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%
Current Liabilities1.37 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%

About Amdocs Performance

Evaluating Amdocs' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Amdocs has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Amdocs has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.13  0.10 
Return On Capital Employed 0.15  0.14 
Return On Assets 0.07  0.06 
Return On Equity 0.13  0.07 

Things to note about Amdocs performance evaluation

Checking the ongoing alerts about Amdocs for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Amdocs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Evaluating Amdocs' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Amdocs' stock performance include:
  • Analyzing Amdocs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Amdocs' stock is overvalued or undervalued compared to its peers.
  • Examining Amdocs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Amdocs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Amdocs' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Amdocs' stock. These opinions can provide insight into Amdocs' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Amdocs' stock performance is not an exact science, and many factors can impact Amdocs' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Amdocs Stock Analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.